BioSpace News Archive

SpinalCyte, LLC, a Texas-based regenerative medicine company focused on regrowth of the spinal disc using Human Dermal Fibroblasts (HDFs), today announced that Pete O’Heeron, SpinalCyte’s Chief Executive Officer, will present at the China Focus @ Europe Vienna on Wednesday, March 27, 2019 at 3:00 PM CET in Vienna, Austria.

The National Association for Behavioral Healthcare Board of Trustees on Monday approved a resolution that addresses unfair managed-care practices and recommends guiding principles for providers and payers to incorporate in contracts with managed care organizations.

Luxia Scientific, a French biotech dedicated to improving wellbeing and health for all through the analysis and understanding of the microbiome, announced today that it has signed an exclusive distribution agreement with Life Genomics to commercialize « 1test1TM » in Nordic countries (Denmark, Finland, Iceland, Norway and Sweden).

Amphera B.V., an advanced-clinical-stage biotechnology company developing dendritic cell therapies to treat cancer, announces that it has recruited the first patients to its pivotal phase II/III study of MesoPher to treat pleural mesothelioma, a rare cancer of the lining of the lungs.

CannTrust Holdings Inc. announces that it has filed a short form base shelf prospectus with the securities commissions in each of the provinces of Canada, except Québec, and a corresponding shelf registration statement on Form F-10 with the U.S. Securities and Exchange Commission under the U.S./Canada Multijurisdictional Disclosure System.

Allergy Therapeutics plc (AIM: AGY), the fully integrated commercial biotechnology company specialising in allergy vaccines, today announced top-line results from the Phase III clinical trial B301of its new adjuvanted birch allergoid product

Increases in chronic inflammation – not the passage of time – is the main reason why injured bones do not heal as well with age.

Apollo Medical Holdings, Inc., an integrated population health management company, announced its consolidated 2018 consolidated financial results for the year ended December 31, 2018.

National Mobile X-Ray, LLC, headquartered in Lakeway, TX, announces the acquisition of MMDS Mobile X-Ray.

Presentation at American College of Cardiology shows TAVR outcomes equivalent to surgery, Hoag among clinical trial sites